Reporting of Administration Site Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks –Analysis of the FAERS Database 2009 to 2022

Tachdjian R, Savic S, Fridman M, Frade J, Audhya PK

Preferences of People with Hereditary Angioedema for On-Demand Treatment: A US-Based Qualitative Study

Bukstein D, Desai V, Goga L, Brown M, Settipane RA

Characterizing Attack-Related Health Utility in Hereditary Angioedema

Craig T, Cribbs KA, Czado S

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

Craig T, Cribbs KA, Czado S

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

Craig T, Cribbs KA, Czado S

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

Schwander B, Lahue BJ, Cribbs KA, Czado S

Rationale for the Short-term Prophylaxis Regimen with Sebetralstat in KONFIDENT-S

Iverson M, Duckworth E, Hansen E, Hampton SL, Smith MD, Audhya PK, Yea CM

C1 Inhibitor Workshop 2023

HAE Patients Decision to Carry On-demand Treatment When Away from Home

Betschel S, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M

C1 Inhibitor Workshop 2023

Route of Administration Preferences of People with Hereditary Angioedema for On-demand Treatment: A US-based Qualitative Study

Desai V, Ledia Goga L, Czado S, Brown M, Myers K, Bukstein D, Audhya PK, Bouillet L

C1 Inhibitor Workshop 2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Soteres DF, Cribbs KA, Guo W, Czado S